期刊文献+

终末期肝病模型评估失代偿期肝硬化患者预后的价值 被引量:8

Values of end-stage liver disease model in assessment of prognosis in patients with decompensated liver cirrhosis
暂未订购
导出
摘要 目的:评价终末期肝病模型(model for end-stage liver disease,MELD)对肝硬化患者短期预后预测的价值.方法:对肝硬化失代偿期患者203例进行回顾性分析,随访患者在3、6及12mo内的预后.记录每例患者入院第1天的MELD及Child-Turcotte-Pugh(CTP)评分.应用接受者工作特征曲线(ROC曲线)及其曲线下面积(AUC)比较MELD、CTP评估患者生存时间的准确性.依据ROC曲线的截断值绘制Kaplan-Meier生存曲线,应用非参数秩相关即Spearman等级相关检验分析MELD与CTP评分的相关性.结果:3、6及12mo内分别死亡23、39、85例,MELD评分与CTP评分均显著相关(r=0.76,0.69,0.71,均P<0.01).3、6及12mo内MELD与CTP对住院患者预后预测的AUC分别为0.886和0.775(P<0.01)、0.892和0.876(P>0.05)、0.873和0.866(P>0.05).生存分析表明2评分系统均可有效预测3、6及12mo内患者可能的生存率和死亡率(P<0.01).结论:MELD模型可预测失代偿肝硬化患者12mo内的生存率,3mo内MELD模型优于CTP评分,但6mo及12mo内MELD模型和CTP评分相比没有明显优势. AIM: To compare the prognostic values of for end-stage liver disease (MELD) model and Child-Turcotte-Pugh (CTP) for patients with decompensated liver cirrhosis. METHODS: From a previously collected database, 203 patients with decompensated liver cirrhosis admitted to our hospital were studied and followed up at least for one year. MELD and CTP score and classification were calculated on entry. Receiver operating characteristics curves (ROC) and the area under ROC were used to determine the ability of the scores for predicting three, six and twelve month mortality. KaplanMeier survival analysis (K-M) was performed using the cut-offs to establish the predictive power of each score. RESULTS: There were 23, 39 and 85 dead cases within 3, 6 and 12 mo respectively. There was a significant correlation between the MELD and CTP score in 3, 6 and 12 mo (r = 0.76, 0.69, 0.71, P 〈 0.01). The areas under the receiver operating characteristics curves of MELD and CTP for the occurrence of death in 3 mo were 0.886 and 0.775. There was a significant difference in the 3 mo between two scores (P 〈 0.01). The areas under the receiver operating characteristics curves for MELD was 0.892 compared with 0.876 for CTP at 6 mo (P 〉 0.05); the area was 0.873 and 0.886 respectively at 12 mo (P 〉 0.05). Both MELD and CTP scores predicted the death rate and survival rate within 3, 6 and 12 mo by survival analysis (P 〈 0.01). CONCLUSION: MELD is a strong prognosis predictor for the decompensated liver cirrhosis. MELD was significantly better than CTP score for predicting in-hospital mortality in 3 too. However, these are not superior to CTP score and CTP classification in 6 and 12 mo.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第17期1786-1790,共5页 World Chinese Journal of Digestology
关键词 终末期肝病模型 肝硬化失代偿期 Child-Turcotte—Pugh评分 Liver cirrhosis Model for end-stage liver disease Child-turcotte-pugh system
  • 相关文献

参考文献6

二级参考文献85

  • 1DINGHui-guo,XIANGHai-ping,SHANJing,ZHOULi,MABing,LIUMin,WANGJun-tao.A scoring model for predicting the prognosis of severe viral hepatitis[J].Chinese Medical Journal,2005(3):249-251. 被引量:13
  • 2Hui-GuoDing JingShan BinZhang Hong-BoMa LiZhou RuiJin Yu-FenTan Li-XiangHe.Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B[J].World Journal of Gastroenterology,2005,11(19):2981-2983. 被引量:13
  • 3蒋道荣,姚登福,孟宪镛.慢性肝病患者HCV与HBV重叠感染与预后[J].新消化病学杂志,1996,4(8):454-455. 被引量:2
  • 4Kiminori Uka,Hiroshi Aikata,Shintaro Takaki,Hiroo Shirakawa,Soo Cheol Jeong,Keitaro Yamashina,Akira Hiramatsu,Hideaki Kodama,Shoichi Takahashi,Kazuaki Chayama.Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(3):414-420. 被引量:54
  • 5[29]Filsoufi F,Salzberg SP,Rahmanian PB,Schiano TD,Elsiesy H,Squire A,Adams DH.Early and late outcome of cardiac surgery in patients with liver cirrhosis.Liver Transpl 2007; 13:990-995
  • 6[30]Eagle KA,Berger PB,Calkins H,Chaitman BR,Ewy GA,Fleischmann KE,Fleisher LA,Froehlich JB,Gusberg RJ,Leppo JA,Ryan T,Schlant RC,Winters WL Jr,Gibbons RJ,Antman EM,Alpert JS,Faxon DP,Fuster V,Gregoratos G,Jacobs AK,Hiratzka LF,Russell RO,Smith SC Jr.ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).Circulation 2002; 105:1257-1267
  • 7[1]Friedman LS.The risk of surgery in patients with liver disease.Hepatology 1999; 29:1617-1623
  • 8[2]Maze M,Bass NM.Anesthesia and the Hepatobiliary System.In:Miller RD.Anesthesia.5th ed.Edinburgh:Churchill Livingstone,2000:1960-1973
  • 9[3]Ngai SH.Effects of anesthetics on various organs.N Engl J Med 1980; 302:564-566
  • 10[4]Srrunin L.Anesthetic management of patients with liver disease.In:Millward-Sadler GH,Wright R,Arthur MJ.Liver and Biliary Disease.London:Saunders,1992:1381-1391

共引文献68

同被引文献61

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部